Elizabeth G. Ingram
Chief Executive Officer presso Cipla Therapeutics, Inc.
Profilo
Elizabeth G.
Ingram is currently the President & Chief Executive Officer at Cipla Therapeutics, Inc. She previously served as an Independent Director at Avenue Therapeutics, Inc. from 2019 to 2022.
Prior to that, she was the Vice President-Market Access Strategy at Bristol Myers Squibb Co. from 2012 to 2014.
Elizabeth also held the position of Chief Marketing Officer at MannKind Corp.
in 2018 and was the Senior Vice President-Managed Market at DexCom, Inc. in 2017.
She completed her undergraduate degree at East Carolina University and her graduate degree at the University of South Carolina.
Posizioni attive di Elizabeth G. Ingram
Società | Posizione | Inizio |
---|---|---|
Cipla Therapeutics, Inc. | Chief Executive Officer | - |
Precedenti posizioni note di Elizabeth G. Ingram
Società | Posizione | Fine |
---|---|---|
AVENUE THERAPEUTICS, INC. | Director/Board Member | 31/10/2022 |
MANNKIND CORPORATION | Sales & Marketing | 01/06/2019 |
DEXCOM, INC. | Corporate Officer/Principal | 01/12/2017 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2014 |
Formazione di Elizabeth G. Ingram
East Carolina University | Undergraduate Degree |
University of South Carolina | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
MANNKIND CORPORATION | Health Technology |
DEXCOM, INC. | Health Technology |
AVENUE THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Cipla Therapeutics, Inc. |
- Borsa valori
- Insiders
- Elizabeth G. Ingram